Drugs & Targets FDA grants Priority Review for Keytruda in head and neck squamous cell carcinoma February 15, 2019Vol.45 No.07
Drugs & Targets FDA accepts sBLA and grants Priority Review for Bavencio + Inlyta in RCC February 15, 2019Vol.45 No.07
Drugs & TargetsFree FDA approves therapy for adult patients with blood clotting disorder February 08, 2019Vol.45 No.06
Drugs & TargetsFree Pfizer given positive CHMP opinion for Vizimpro in NSCLC February 08, 2019Vol.45 No.06
Drugs & TargetsFree Genentech submits sBLA for Kadcyla for breast cancer February 08, 2019Vol.45 No.06
Drugs & TargetsFree Merck KGaA and GSK to co-develop immunotherapy M7824 February 08, 2019Vol.45 No.06
Drugs & TargetsFree FDA pursues order to bar some retailers from selling tobacco in efforts to target tobacco use by minors February 08, 2019Vol.45 No.06
Drugs & TargetsFree Alimta + Keytruda and platinum chemo for NSCLC gets FDA label expansion February 01, 2019Vol.45 No.05
Drugs & TargetsFree Trovagene and PoC Capital agree to fund clinical development of onvansertib in metastatic colorectal cancer February 01, 2019Vol.45 No.05
